Abstract
Haemophilia is a rare congenital bleeding disorder that generally affects men. A lack of clotting factor increases the risk of bleeding, which can be prevented and treated with regular, prophylactic, intravenous clotting factor concentrate (CFC) replacement therapy. However, prophylaxis effectiveness depends on continuous adherence, which is estimated at 50%–80%. The
... read more